CROSBY Research – OrbusNeich Medical (6929 HK/ NR): Fuel growth through portfolio and capacity expansion

18 Aug 2025

OrbusNeich is a global medical device company focused on interventional technologies for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) has announced its 1H25 results. In 1H25, the company faced considerable challenges stemming from a complex macroeconomic environment and evolving geopolitical tensions.